Please ensure Javascript is enabled for purposes of website accessibility

Why Buckeye Partners, Guardant Health, and Chico's FAS Jumped Today

By Dan Caplinger – May 10, 2019 at 4:28PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Earnings and acquisition activity helped make these stocks stand out.

The stock market had another volatile session on Friday, clawing its way back from precipitous declines early in the day to finish with solid gains. Despite the rising tensions on trade between the U.S. and China, investors seem to be resolute in their belief that the U.S. economy will be able to keep outperforming the rest of the world and producing solid growth. Good news from certain key companies also helped to bolster sentiment. Buckeye Partners (BPL), Guardant Health (GH 1.86%), and Chico's FAS (CHS -3.72%) were among the top performers. Here's why they did so well.

Buckeye gets bought

Partnership units of Buckeye Partners soared 28% after the master limited partnership received a buyout bid. Institutional investor IFM Global Infrastructure Fund agreed with Buckeye to buy all of its outstanding units for $41.50 per unit in cash. The deal puts an enterprise value of $10.3 billion on Buckeye, which has an extensive network of pipelines, delivery locations, and terminals for transporting energy products. The move is the logical conclusion of Buckeye's review of its strategic options, although the fact that units traded above the $41.50 offering price suggests at least some hope that other bidders will emerge for the master limited partnership.

Oil storage tanks and pipelines at a network facility.

Image source: Buckeye Partners.

Guardant looks healthy

Guardant Health saw its shares jump more than 18% following the release of the oncology testing specialist's first-quarter financial results. Guardant said that revenue more than doubled from year-ago levels, with substantial increases in the number of tests it conducted for clinical and biopharmaceutical customers during the period. The company also raised its revenue guidance for the full year, expecting to see $145 million to $150 million on the top line. That's higher by $15 million from previous guidance, and even though Guardant continues to lose money, investors are optimistic that it has carved out a lucrative niche.

Chico's gets a lowball offer

Finally, shares of Chico's FAS finished higher by 8%. The ailing retailer received a bid from private equity company Sycamore Partners to purchase its stock for $3.50 per share. The odd thing about the move is that Chico's shares started the day at $3.70, making it unlikely that the retailer will accept the deal. Chico's did say that it would review the unsolicited bid from Sycamore, which owns 6.6% of the company's stock. Yet the share-price move today suggests that shareholders will want more than $3.50 per share in order to accept a buyout bid -- even with its long struggles.

Dan Caplinger has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Guardant Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Chico's FAS, Inc. Stock Quote
Chico's FAS, Inc.
$4.66 (-3.72%) $0.18
Buckeye Partners, L.P. Stock Quote
Buckeye Partners, L.P.
Guardant Health, Inc. Stock Quote
Guardant Health, Inc.
$54.83 (1.86%) $1.00

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/04/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.